Nifty

:

25795.15

Sensex

:

84211.88

-96.25 (-0.37%)
-344.52 (-0.41%)

Login

Nifty
Sensex

:
:

25795.15
84211.88

-96.25 (-0.37%)
-344.52 (-0.41%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

51/99

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

341.70

24-Oct-2025

Open
High
Low
Previous Close

345.75
347.4
337.2
344.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

35695
12186767.3
504.25
298.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,422.14
55.32
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,703.49
0.03%
5.57

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.03
10.95
5.88

EBITDA CAGR (%)

10 Years
5 Years
3 Years

21.35
10.20
0.26

PAT CAGR (%)

10 Years
5 Years
3 Years

25.32
9.59
-4.27

P:E (Median)

8 Years
5 Years
3 Years

48.31
48.31
48.31

P:BV (Average)

8 Years
5 Years
3 Years

4.94
4.94
4.94

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.65
21.65
21.65

Earnings Forecasts:

(Updated: 25-10-2025)

Description 2024 2025 2026 2027
Adj EPS 6.95
P/E Ratio 49.17
Revenue 819.81
EBITDA 134.69
Net Income 69.65
ROA 6.16
P/B Ratio 5.70
ROE 12.29
FCFF 31.86
FCFF Yield 0.8
Net Debt 320.47
BVPS 59.94

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 226.91 202.81 11.88% 205.02 194.99 5.14% 207.79 201.78 2.98% 204.18 214.87 -4.98%
Expenses 194.58 167.03 16.49% 178.38 160.77 10.95% 173.85 165.32 5.16% 165.56 175.50 -5.66%
EBITDA 32.33 35.78 -9.64% 26.64 34.23 -22.17% 33.94 36.45 -6.89% 38.62 39.37 -1.91%
EBIDTM 14.25% 17.64% 12.99% 17.55% 16.33% 18.07% 18.92% 18.32%
Other Income 0.89 1.26 -29.37% 0.38 0.88 -56.82% 1.86 0.42 342.86% 0.11 0.33 -66.67%
Interest 9.23 4.62 99.78% 8.40 3.65 130.14% 4.91 3.18 54.40% 5.18 4.46 16.14%
Depreciation 7.72 4.30 79.53% 7.84 4.34 80.65% 4.62 4.14 11.59% 4.30 4.30 0.00%
PBT 16.28 28.11 -42.08% 10.78 27.12 -60.25% 26.28 29.56 -11.10% 29.26 30.95 -5.46%
Tax 4.20 7.25 -42.07% 2.81 7.07 -60.25% 6.96 7.30 -4.66% 7.48 7.74 -3.36%
PAT 12.07 20.86 -42.14% 7.97 20.05 -60.25% 19.32 22.26 -13.21% 21.78 23.21 -6.16%
PATM 5.32% 10.28% 3.89% 10.28% 9.30% 11.03% 10.67% 10.80%
EPS 1.20 2.08 -42.31% 0.80 2.00 -60.00% 1.93 2.22 -13.06% 2.17 2.31 -6.06%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 223.72 202.81 10.31% 205.02 194.99 5.14% 207.79 201.78 2.98% 204.18 214.87 -4.98%
Expenses 190.42 167.03 14.00% 178.65 160.77 11.12% 173.87 165.32 5.17% 165.56 175.50 -5.66%
EBITDA 33.30 35.78 -6.93% 26.37 34.23 -22.96% 33.92 36.45 -6.94% 38.62 39.37 -1.91%
EBIDTM 14.89% 17.64% 12.86% 17.55% 16.33% 18.07% 18.91% 18.32%
Other Income 0.93 1.26 -26.19% 0.39 0.88 -55.68% 1.86 0.42 342.86% 0.11 0.33 -66.67%
Interest 9.23 4.62 99.78% 8.40 3.65 130.14% 4.91 3.18 54.40% 5.18 4.46 16.14%
Depreciation 7.72 4.30 79.53% 7.84 4.34 80.65% 4.62 4.14 11.59% 4.30 4.30 0.00%
PBT 17.27 28.11 -38.56% 10.53 27.12 -61.17% 26.26 29.56 -11.16% 29.25 30.95 -5.49%
Tax 4.20 7.25 -42.07% 2.81 7.07 -60.25% 6.96 7.30 -4.66% 7.48 7.74 -3.36%
PAT 13.07 20.86 -37.34% 7.72 20.05 -61.50% 19.31 22.26 -13.25% 21.77 23.21 -6.20%
PATM 5.84% 10.28% 3.77% 10.28% 9.29% 11.03% 10.66% 10.80%
EPS 1.30 2.08 -37.50% 0.77 2.00 -61.50% 1.93 2.22 -13.06% 2.17 2.39 -9.21%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 843.90 819.81 806.67 690.62 779.16 487.70 378.84 350.77 305.58 245.52 202.20 Net Sales Growth 3.62% 1.63% 16.80% -11.36% 59.76% 28.74% 8.00% 14.79% 24.46% 21.42% Cost Of Goods Sold 385.26 309.97 339.06 295.46 368.49 226.12 156.47 161.37 128.58 107.42 90.84 Gross Profit 458.64 509.84 467.60 395.16 410.67 261.58 222.37 189.40 177.01 138.10 111.35 GP Margin 54.35% 62.19% 57.97% 57.22% 52.71% 53.64% 58.70% 54.00% 57.93% 56.25% 55.07% Total Expenditure 712.37 683.41 659.37 555.97 631.13 403.78 326.72 304.78 266.80 222.57 182.51 Power & Fuel Cost - 18.46 17.61 15.24 11.00 9.94 8.23 3.43 3.58 3.51 3.57 % Of Sales - 2.25% 2.18% 2.21% 1.41% 2.04% 2.17% 0.98% 1.17% 1.43% 1.77% Employee Cost - 127.19 109.67 86.73 85.61 66.22 58.59 46.85 44.62 41.03 31.95 % Of Sales - 15.51% 13.60% 12.56% 10.99% 13.58% 15.47% 13.36% 14.60% 16.71% 15.80% Manufacturing Exp. - 106.44 89.75 72.21 82.20 46.74 43.26 43.16 37.69 28.94 23.54 % Of Sales - 12.98% 11.13% 10.46% 10.55% 9.58% 11.42% 12.30% 12.33% 11.79% 11.64% General & Admin Exp. - 61.77 54.18 44.70 37.97 23.69 32.47 32.32 31.50 27.03 20.56 % Of Sales - 7.53% 6.72% 6.47% 4.87% 4.86% 8.57% 9.21% 10.31% 11.01% 10.17% Selling & Distn. Exp. - 47.57 40.20 31.74 28.38 17.87 17.35 11.36 13.26 9.11 8.19 % Of Sales - 5.80% 4.98% 4.60% 3.64% 3.66% 4.58% 3.24% 4.34% 3.71% 4.05% Miscellaneous Exp. - 12.03 8.89 9.88 17.48 13.20 10.36 6.29 7.57 5.53 8.19 % Of Sales - 1.47% 1.10% 1.43% 2.24% 2.71% 2.73% 1.79% 2.48% 2.25% 1.90% EBITDA 131.53 136.40 147.30 134.65 148.03 83.92 52.12 45.99 38.78 22.95 19.69 EBITDA Margin 15.59% 16.64% 18.26% 19.50% 19.00% 17.21% 13.76% 13.11% 12.69% 9.35% 9.74% Other Income 3.24 3.62 2.18 2.57 3.10 3.73 5.79 4.17 2.86 1.44 0.66 Interest 27.72 24.52 16.79 8.22 5.37 13.63 13.91 10.16 8.88 6.34 6.20 Depreciation 24.48 21.06 17.02 22.28 18.93 16.31 13.86 4.65 4.40 3.68 3.79 PBT 82.60 94.43 115.67 106.72 126.84 57.71 30.13 35.35 28.37 14.37 10.36 Tax 21.45 24.49 29.54 27.02 31.00 13.48 7.44 13.41 13.48 5.35 3.03 Tax Rate 25.97% 25.93% 25.54% 25.32% 24.44% 23.36% 24.69% 37.93% 44.99% 37.23% 29.25% PAT 61.14 69.93 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 PAT before Minority Interest 61.14 69.93 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.24% 8.53% 10.68% 11.54% 12.30% 9.07% 5.99% 6.25% 5.39% 3.67% 3.62% PAT Growth -29.22% -18.82% 8.08% -16.84% 116.69% 94.93% 3.42% 33.13% 82.71% 23.22% EPS 6.10 6.97 8.59 7.95 9.56 4.41 2.26 2.19 1.64 0.90 0.73

Description TTM Mar 25 Mar 24
Net Sales 840.71 819.81 806.67 Net Sales Growth 3.22% 1.63% Cost Of Goods Sold 380.73 309.97 339.06 Gross Profit 459.98 509.84 467.60 GP Margin 54.71% 62.19% 57.97% Total Expenditure 708.50 683.71 659.37 Power & Fuel Cost - 18.46 17.61 % Of Sales - 2.25% 2.18% Employee Cost - 127.19 109.67 % Of Sales - 15.51% 13.60% Manufacturing Exp. - 106.44 89.75 % Of Sales - 12.98% 11.13% General & Admin Exp. - 62.06 54.18 % Of Sales - 7.57% 6.72% Selling & Distn. Exp. - 47.57 40.20 % Of Sales - 5.80% 4.98% Miscellaneous Exp. - 12.04 8.89 % Of Sales - 1.47% 1.10% EBITDA 132.21 136.10 147.30 EBITDA Margin 15.73% 16.60% 18.26% Other Income 3.29 3.63 2.18 Interest 27.72 24.52 16.79 Depreciation 24.48 21.06 17.02 PBT 83.31 94.14 115.67 Tax 21.45 24.49 29.54 Tax Rate 25.75% 26.01% 25.54% PAT 61.87 69.65 86.14 PAT before Minority Interest 61.87 69.65 86.14 Minority Interest 0.00 0.00 0.00 PAT Margin 7.36% 8.50% 10.68% PAT Growth -28.37% -19.14% EPS 6.17 6.94 8.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 601.36 532.56 347.81 269.12 173.44 129.32 75.35 54.14 37.33 33.96 Share Capital 10.03 10.03 9.69 9.69 9.69 9.69 7.78 7.78 7.74 7.74 Total Reserves 591.23 522.53 338.11 259.42 163.74 119.63 67.56 46.35 29.59 26.22 Non-Current Liabilities 180.73 187.93 224.18 65.88 54.96 37.79 17.16 12.54 9.16 14.56 Secured Loans 130.50 153.96 190.68 47.98 35.43 19.52 11.25 4.43 3.20 4.84 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.03 0.06 3.89 3.42 2.82 Long Term Provisions 17.49 15.38 13.29 12.39 10.23 7.93 1.86 2.26 2.29 1.39 Current Liabilities 387.53 372.05 288.21 186.40 163.66 325.60 217.72 168.55 128.18 103.68 Trade Payables 158.75 166.27 130.26 140.95 111.21 117.07 77.81 75.98 43.74 52.62 Other Current Liabilities 70.14 56.48 38.82 33.30 29.98 22.99 16.28 17.24 20.75 14.10 Short Term Borrowings 154.27 142.02 111.76 6.60 16.32 93.10 84.69 69.17 46.97 32.28 Short Term Provisions 4.38 7.28 7.37 5.55 6.15 92.44 38.95 6.16 16.73 4.67 Total Liabilities 1,169.62 1,092.54 860.20 521.40 392.06 492.71 310.23 235.23 174.67 152.20 Net Block 505.99 158.89 159.57 115.17 99.97 82.58 24.45 22.85 21.96 22.15 Gross Block 614.12 246.23 246.28 179.65 148.64 114.98 37.19 31.00 25.65 51.31 Accumulated Depreciation 108.13 87.34 86.71 64.48 48.67 32.40 12.74 8.15 3.68 29.17 Non Current Assets 545.85 492.07 396.08 200.65 131.48 133.58 46.34 37.02 31.42 32.69 Capital Work in Progress 21.82 307.06 169.59 40.87 13.40 30.61 9.63 2.05 0.04 0.00 Non Current Investment 2.81 1.79 0.78 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 13.17 23.12 64.35 43.65 17.12 18.54 10.16 8.73 7.60 9.01 Other Non Current Assets 2.06 1.21 1.80 0.95 0.98 1.84 2.09 3.38 1.82 1.52 Current Assets 623.78 600.47 464.11 320.75 260.58 359.13 263.89 198.20 143.25 119.51 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 216.87 200.48 183.46 115.57 94.40 122.46 94.28 94.20 63.02 50.26 Sundry Debtors 314.61 329.94 205.47 151.55 124.50 106.97 103.18 80.80 52.12 56.23 Cash & Bank 28.21 13.47 46.69 26.57 13.18 16.37 7.59 7.50 5.64 6.16 Other Current Assets 64.09 3.75 1.79 0.86 28.50 113.32 58.84 15.71 22.47 6.86 Short Term Loans & Adv. 62.52 52.83 26.71 26.21 27.81 112.48 57.74 15.33 21.38 6.10 Net Current Assets 236.24 228.42 175.90 134.35 96.92 33.53 46.17 29.66 15.07 15.84 Total Assets 1,169.63 1,092.54 860.19 521.40 392.06 492.71 310.23 235.22 174.67 152.20

Description Mar 25 Mar 24
Shareholder's Funds 601.08 532.56 Share Capital 10.03 10.03 Total Reserves 590.94 522.53 Non-Current Liabilities 180.73 187.93 Secured Loans 130.50 153.96 Unsecured Loans 0.00 0.00 Long Term Provisions 17.49 15.38 Current Liabilities 387.56 372.05 Trade Payables 158.75 166.27 Other Current Liabilities 70.14 56.48 Short Term Borrowings 154.27 142.02 Short Term Provisions 4.40 7.28 Total Liabilities 1,169.37 1,092.54 Net Block 505.99 158.89 Gross Block 614.12 246.23 Accumulated Depreciation 108.13 87.34 Non Current Assets 544.84 492.06 Capital Work in Progress 21.82 307.06 Non Current Investment 1.78 1.78 Long Term Loans & Adv. 13.18 23.12 Other Non Current Assets 2.06 1.21 Current Assets 624.52 600.48 Current Investments 0.00 0.00 Inventories 216.87 200.48 Sundry Debtors 314.61 329.94 Cash & Bank 29.02 13.48 Other Current Assets 64.02 3.75 Short Term Loans & Adv. 62.52 52.83 Net Current Assets 236.97 228.43 Total Assets 1,169.36 1,092.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 122.78 -7.46 -26.59 106.24 87.25 47.10 5.21 -4.82 -4.13 -4.32 PBT 94.43 115.67 106.72 126.84 57.71 30.13 35.35 29.95 14.37 11.19 Adjustment 43.79 34.15 29.64 23.18 30.79 24.63 13.35 12.07 9.75 8.84 Changes in Working Capital 7.37 -130.23 -135.25 -10.72 8.15 2.48 -33.52 -30.40 -23.70 -21.31 Cash after chg. in Working capital 145.59 19.59 1.11 139.30 96.65 57.24 15.18 11.63 0.42 -1.28 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -22.81 -27.04 -27.70 -33.06 -9.40 -10.14 -9.98 -16.44 -4.55 -2.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 Cash From Investing Activity -71.79 -102.40 -190.73 -94.59 -6.69 -42.53 -12.99 -8.84 -4.69 -0.51 Net Fixed Assets -82.65 -137.42 -195.35 -58.48 -16.45 -98.77 -13.77 -7.36 25.62 -0.50 Net Investments -1.02 -1.01 -0.77 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 11.88 36.03 5.39 -36.11 9.76 56.24 0.78 -1.48 -30.31 -0.01 Cash from Financing Activity -37.20 82.38 234.31 -6.24 -78.62 -4.21 7.71 14.40 7.41 4.78 Net Cash Inflow / Outflow 13.78 -27.48 16.99 5.41 1.94 0.37 -0.08 0.75 -1.41 -0.05 Opening Cash & Equivalents 1.13 28.60 11.61 6.20 4.26 3.90 3.74 2.99 4.28 6.21 Closing Cash & Equivalent 14.91 1.13 28.60 11.61 6.20 4.26 3.66 3.74 2.87 6.16

Description Mar 25 Mar 24
Cash From Operating Activity 122.57 -7.46 PBT 94.14 115.67 Adjustment 43.79 34.15 Changes in Working Capital 7.44 -130.23 Cash after chg. in Working capital 145.38 19.59 Interest Paid 0.00 0.00 Tax Paid -22.81 -27.04 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -70.78 -102.39 Net Fixed Assets -82.65 Net Investments -1.02 Others 12.89 Cash from Financing Activity -37.20 82.38 Net Cash Inflow / Outflow 14.59 -27.46 Opening Cash & Equivalents 1.14 28.60 Closing Cash & Equivalent 15.72 1.14

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 59.96 53.11 35.88 27.76 17.89 13.34 9.68 6.96 4.83 4.39 ROA 6.18% 8.82% 11.54% 20.98% 10.00% 5.65% 8.04% 8.04% 5.52% 5.24% ROE 12.34% 19.57% 25.84% 43.31% 29.22% 22.17% 33.89% 36.03% 25.31% 23.99% ROCE 13.51% 17.56% 23.23% 47.29% 30.05% 21.01% 29.65% 34.10% 24.26% 24.24% Fixed Asset Turnover 2.56 3.82 3.76 5.17 3.94 5.14 10.57 11.21 6.77 4.19 Receivable days 106.89 103.93 81.36 59.40 81.43 97.98 93.16 76.39 75.93 76.38 Inventory Days 69.22 74.53 68.14 45.18 76.30 101.05 95.44 90.36 79.39 74.21 Payable days 191.37 159.61 167.52 124.89 184.25 115.05 115.32 80.93 87.99 110.87 Cash Conversion Cycle -15.25 18.85 -18.02 -20.30 -26.52 83.98 73.27 85.82 67.32 39.73 Total Debt/Equity 0.52 0.60 0.90 0.23 0.32 0.90 1.30 1.47 1.52 1.26 Interest Cover 4.85 7.89 13.98 24.64 5.23 3.17 4.48 4.37 3.27 2.67

Description Mar 25 Mar 24
Book Value (Rs.) 59.93 53.11 ROA 6.16% 7.88% ROE 12.29% 16.17% ROCE 13.48% 15.59% Fixed Asset Turnover 2.56 3.82 Receivable days 106.89 128.09 Inventory Days 69.22 77.83 Payable days 191.37 178.99 Cash Conversion Cycle -15.25 26.94 Total Debt/Equity 0.52 0.60 Interest Cover 4.84 7.89

Top Investors:

motilal oswal financial services ltd

jagdish n master

motilal oswal small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Gufic Biosciences makes investment in Gufic Ireland
26th Aug 2025, 12:38 PM

Gufic Ireland shall carry on the business of marketing, distribution, purchase and sale of pharmaceutical products
Read More
Gufic Biosciences - Quarterly Results
13th Aug 2025, 19:01 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback